Innovative providers, collaborations and payment strategies credited for increase.
Indianapolis—Anthem Blue Cross and Blue Shield more than the doubled the number of members in Medicaid, individual and employer-sponsored plans receiving whole-person therapies believed to produce better outcomes for opioid use disorder.
To make a positive impact on member health and lessen the impact of the opioid epidemic, Anthem pledged four years ago to ensure significantly more members received both drug therapy and counseling treatment in an effort to treat both mind and body.
Anthem met these goals by boosting the combined percentage of consumers in employer-based, individual and Medicaid plans with opioid use disorder receiving both therapies from 22% to 56%. Medicaid plans alone increased from 24% to 65%.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Addressing the Bidirectional Impact of Schizophrenia and Substance Use Disorders
February 8th 2025Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and substance use disorders in an interview.
Read More